Sakar Healthcare Limited

Web: sakarhealthcare.com NSE: SAKAR SECTOR: Healthcare - Pharmaceuticals & Biotechnology

820 17(-2%)

Volume

1L as on 23, Jun

Open

306

High

306

Low

289

837

VWAP

819

52 Week High

960

52 Week Low

311

Viand Research Rating

Quality Score

65/100

Growth Score

98/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,825

No. of Shares

2.22

P/E

P/B

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

11-Apr-19

Promoter Holding

52.86%

FII Holding

12.94%

DII Holding

11.32%

Price Chart

Price Performance

1 Week1%

1 Month7%

3 Months61%

6 Months51%

1 Year51%

YTD51%

Moving Average

5 Day SMA806

10 Day SMA817

20 Day SMA809

30 Day SMA779

50 Day SMA710

61 Day SMA676

80 Day SMA314

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	857	826	842	859
Resistance 2	842	824	832	844
Resistance 1	831	821	826	833
Pivot Point	816	819	816	818
Support 1	805	816	806	807
Support 2	790	814	800	792
Support 3	779	812	790	781

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 52.86%	(0.01) 52.86%	(0.01) 52.86%	(-0.71) 52.86%	(0.01) 53.58%	(0.41) 53.58%	(0.01) 53.15%	(0.01) 53.15%	(0.01) 53.15%	(-1.01) 53.15%	(-6.61) 54.15%	(0.01) 60.72%	(-1.41) 60.72%	(0.01) 62.10%	(-5.41) 62.10%	(0.01) 67.54%	(0.01) 67.54%	(0.01) 67.54%	(0.01) 67.54%
FIIs	(-0.11) 12.94%	(-0.31) 13.05%	(-0.11) 13.31%	(-0.21) 13.41%	(0.01) 13.61%	(0.21) 13.58%	(-0.11) 13.42%	(0.01) 13.52%	(-0.21) 13.52%	(-0.31) 13.76%	(-1.71) 14.03%	(0.01) 15.74%	(-0.41) 15.74%	(0.01) 16.12%	(16.11) 16.12%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 11.32%	(-0.11) 11.36%	(0.21) 11.43%	(0.31) 11.25%	(0.11) 10.97%	(0.31) 10.88%	(0.01) 10.62%	(0.01) 10.62%	(0.01) 10.62%	(-0.21) 10.62%	(10.81) 10.82%	(0.01) 0.00%	(-0.31) 0.00%	(-0.21) 0.33%	(-8.21) 0.55%	(0.01) 8.76%	(0.01) 8.76%	(0.01) 8.76%	(0.01) 8.76%
Public	22.87%	22.73%	22.41%	22.48%	21.85%	21.96%	22.80%	22.71%	22.71%	22.47%	21.00%	23.54%	23.54%	21.45%	21.24%	23.70%	23.70%	23.70%	23.70%
No. of Shareholders	9,580	7,069	7,565	8,115	8,608	8,598	7,867	7,313	7,386	7,001	7,299	6,056	6,322	6,210	5,678	6,091	6,702	6,542	6,481

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	71	70	58	53	50	43	43	41	43	37	34	39	41	33	30.71	28.53	36.59	29.74	31.64	30.26
Sales Growth % (YoY)	41.5%	62%	34.6%	28.2%	16.7%	16.6%	25.5%	5.5%	5.9%	11.2%	11%	36.7%	11.1%	13%	-2.9%	-5.7%	68.8%	11%	21.1%	50.2%
Sales Growth % (QoQ)	1.4%	20.7%	9.4%	6%	16.3%	-	4.9%	-4.7%	16.2%	8.8%	-12.8%	-4.9%	24.2%	7.5%	7.6%	-22%	23%	-6%	4.6%	-
Expenses	45	52	46	40	35	32	31	30	32	28	25	30	33	25	22.12	20.57	27.48	23.09	24.55	23.77
Operating Profit	26	19	11	13	16	12	12	11	11	9	9	9	8	9	8.59	7.96	9.11	6.65	7.09	6.49
OPM %	37	26	20	24	31	27	27	26	25	24	27	23	19	26	27.97	27.9	24.9	22.36	22.41	21.45
Other Income	0	1	1	0	0	0	0	0	1	0	1	2	2	2	0.6	0.41	0.88	0.27	0.75	0.27
Interest	2	2	2	2	4	1	2	1	2	2	2	2	2	2	0.99	0.86	0.68	0.94	0.79	0.49
Depreciation	6	6	6	6	5	5	5	5	5	4	4	5	4	4	3.77	3.57	3.19	2.62	1.68	2.18
Profit before tax	18	11	5	5	6	5	5	5	5	3	4	4	4	5	4.43	3.94	6.12	3.36	5.37	4.09
Tax %	39	6	15	13	8	17	6	49	35	31	13	28	-1	13	56.21	26.9	-46.24	96.43	54.19	10.51
Net Profit	11	10	5	5	6	5	5	2	3	2	4	3	4	4	1.94	2.88	8.95	0.11	2.46	3.65
Net Profit Growth % (QoQ)	10%	100%	-	-16.7%	20%	-	150%	-33.3%	50%	-50%	33.3%	-25%	-	106.2%	-32.6%	-67.8%	8036.4%	-95.5%	-32.6%	-
Net Profit Growth % (YoY)	83.3%	100%	-	150%	100%	150%	25%	-33.3%	-25%	-50%	106.2%	4.2%	-55.3%	3536.4%	-21.1%	-21.1%	-	-	-	-
TTM Net Profit	31	26	21	21	18	15	12	11	12	13	15	12.94	12.82	17.77	13.88	14.4	15.17	6.22	6.11	0
EPS in Rs	4.95	4.61	2.04	2.1	2.62	2.06	2.21	1.11	1.43	0.95	1.7	1.49	2.06	2.15	1.04	1.68	5.23	0.06	1.44	2.13

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	252	178	153	133	128	95	83	68	53	44	41	35	30	22
Sales Growth %	41.8%	15.8%	15%	4%	35.3%	14.2%	-	28.6%	20.1%	7.1%	17.7%	18%	35.5%	35.3%
Expenses	183	128	115	100	99	72	63	51	40	34	33	27	22	14
Operating Profit	69	50	38	33	29	23	20	17	13	10	8	8	8	8
OPM %	27	28	25	25	23	24	24	25	24	23	20	22	26	34
Other Income	2	1	3	5	2	1	2	1	0	1	0	0	0	0
Interest	8	9	8	6	3	2	2	2	3	3	3	3	4	4
Depreciation	24	21	18	15	10	8	7	6	4	3	3	2	2	2
Profit before tax	40	22	16	17	19	13	12	9	6	5	3	2	2	2
Tax %	23	19	27	24	20	19	21	28	38	30	22	24	13	19
Net Profit	30	18	12	13	15	11	10	7	4	3	2	2	2	1
Net Profit Growth %	66.7%	50%	-7.7%	-13.3%	36.4%	10%	42.9%	75%	33.3%	50%	-	-	100%	-
EPS in Rs	13.7	7.97	5.37	6.7	8.9	6.84	6.43	4.47	3.12	3.08	2.78	2.3	2.19	1.81
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	49	34	24	33	36	15	19	16	5	2	9	4	9	7
Cash from Investing Activity	-28	-31	-52	-74	-90	-47	-22	-25	-8	-14	-4	-1	-3	-3
Cash from Financing Activity	-21	-3	27	41	55	32	3	9	-13	13	-6	-3	-6	-7
Net Cash Flow	0	0	0	0	0	0	0	0	-16	0	-1	1	0	-4

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	22	22	22	22	22	19	17	16	15	15	12	11	8	8	8	8
Reserves	302	281	264	248	241	154	110	83	66	57	39	25	11	7	6	4
Borrowings	55	72	86	74	79	119	93	43	17	11	11	24	22	25	24	27
Other Liabilities	101	73	43	61	47	44	47	37	17	15	18	11	10	11	14	11
Total Liabilities	481	449	415	404	389	336	268	178	115	97	81	71	51	50	52	50
Fixed Assets	326	325	309	317	314	267	205	69	66	64	53	49	37	36	38	37
CWIP	4	17	17	1	0	6	1	49	13	9	0	0	0	0	0	0
Investments	0	0	0	0	0	3	7	0	0	0	0	0	0	0	0	0
Other Assets	151	107	90	87	74	60	55	60	36	25	28	22	14	14	14	13
Total Assets	481	449	415	404	389	336	268	178	115	97	81	71	51	50	52	50

Delivery

#	Date	587 64% 960	Value (Cr)	Q/T 22	Del 43	Del 15
1	22-Jul	837	11	13	53	6
2	21-Jul	879	6	14	54	3
3	20-Jul	899	7	13	40	3
4	17-Jul	878	11	14	45	5
5	16-Jul	897	19	16	36	7
6	15-Jul	917	14	15	44	6
7	14-Jul	904	72	23	28	20
8	13-Jul	864	25	22	45	11
9	10-Jul	824	7	20	52	4
10	9-Jul	800	7	17	47	3
11	8-Jul	800	9	21	53	5
12	7-Jul	823	6	14	45	3
13	6-Jul	835	14	15	40	6
14	3-Jul	849	26	16	35	9
15	2-Jul	834	9	18	51	5
16	1-Jul	812	9	23	57	5
17	30-Jun	838	7	18	58	4
18	29-Jun	832	14	21	52	7
19	25-Jun	808	8	18	45	4
20	24-Jun	828	26	17	31	8
21	23-Jun	812	8	27	53	4
22	22-Jun	819	8	25	54	4
23	19-Jun	804	4	16	49	2
24	18-Jun	796	7	18	50	3
25	17-Jun	801	8	23	65	5
26	16-Jun	823	14	19	37	5
27	15-Jun	844	7	20	53	4
28	12-Jun	824	9	24	63	5
29	11-Jun	803	17	26	41	7
30	10-Jun	839	21	30	55	12
31	9-Jun	814	9	24	60	6
32	8-Jun	768	12	22	43	5
33	5-Jun	773	11	22	52	6
34	4-Jun	815	4	19	60	2
35	3-Jun	813	11	19	41	5
36	2-Jun	835	11	21	43	5
37	1-Jun	836	42	26	37	16
38	29-May	796	12	22	40	5
39	27-May	788	14	23	42	6
40	26-May	786	9	19	45	4
41	25-May	801	20	29	50	10
42	22-May	762	11	23	49	5
43	21-May	787	15	23	46	7
44	20-May	809	24	22	43	10
45	19-May	767	12	17	46	5
46	18-May	780	103	25	21	21
47	15-May	697	78	29	36	28
48	14-May	600	8	23	56	4

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	1,825c	24c	1.31
22-Jul	1,849c	115c	5.84
21-Jul	1,964c	21c	1.10
17-Jul	1,942c	47c	2.34
16-Jul	1,989c	54c	2.64
15-Jul	2,043c	13c	0.63
14-Jul	2,056c	133c	6.94
13-Jul	1,922c	69c	3.75
10-Jul	1,853c	57c	3.20
09-Jul	1,796c	9c	0.50
08-Jul	1,787c	47c	2.57
07-Jul	1,834c	28c	1.52
06-Jul	1,862c	5c	0.25
02-Jul	1,867c	2c	0.12
30-Jun	1,869c	24c	1.30
29-Jun	1,845c	43c	2.38
26-Jun	1,802c	2c	0.10
25-Jun	1,804c	39c	2.12
24-Jun	1,843c	19c	1.04
23-Jun	1,824c	4c	0.24
22-Jun	1,820c	30c	1.65
19-Jun	1,790c	15c	0.84
18-Jun	1,775c	1c	0.06
17-Jun	1,774c	50c	2.74
16-Jun	1,825c	41c	2.21
15-Jun	1,866c	21c	1.15
12-Jun	1,845c	29c	1.54
11-Jun	1,873c	12c	0.65
10-Jun	1,886c	0	0

Stock Checklist

Price is above from 52 week high low average: 57%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

NseIndia | Trendlyne | Screener | TradingView